Source: Annual Congress 2007 - Venous thromboembolic disease
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. A. Andreeva, M. A. Saidova, T. V. Martynyuk, V. P. Masenco, S. N. Nakonechnicov, I. Y. Chazova (Moscow, Russian Federation). Brain natriuretic peptides in patients with idiopathic pulmonary hypertension and chronic thromboembolic disease. Eur Respir J 2007; 30: Suppl. 51, 3559

Member's Comments

No comment yet.

Related content which might interest you: Osteoporosis in patients with idiopathic and chronic thromboembolic pulmonary hypertension Source: Annual Congress 2007 - Pulmonary hypertension in the clinic Year: 2007 Brain natriuretic peptide in patients with acute pulmonary embolism Source: Eur Respir J 2005; 26: Suppl. 49, 270s Year: 2005 The effect of diuretics on plasma brain natriuretic peptide level in patients with acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2007 - Treatment of COPD Year: 2007 N-terminal-pro-brain natriuretic peptide as a haemodynamic marker in idiopathic pulmonary arterial hypertension Source: Eur Respir J 2005; 25: 509-513 Year: 2005 Use of B-type natriuretic peptide in the risk stratification of acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2008 - COPD Year: 2008 Patients with primary or thromboembolic pulmonary hypertension develop renal resistance to ANP and BNP Source: Eur Respir J 2003; 22: Suppl. 45, 463s Year: 2003 Evaluation of serum cytokines in patients with idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension with hypercholesterolemia Source: International Congress 2017 – PAH and CTEPH Year: 2017 Identification of left ventricular systolic dysfunction or pulmonary hypertension in patients with asthma or chronic obstructive pulmonary disease by N-terminal pro-brain natriuretic peptide Source: Annual Congress 2007 - New insight into the pathophysiology of asthma Year: 2007 Diagnosis of chronic thromboembolic pulmonary hypertension Source: Eur Respir Rev 2017; 26: 160108 Year: 2017 Pulmonary function in patients with idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension Source: Annual Congress 2010 - Pulmonary circulation I Year: 2010 N-terminal pro-brain natriuretic peptide is a useful prognostic marker in patients with pulmonary hypertension and renal insufficiency Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I Year: 2013 Pharmacological therapy for patients with chronic thromboembolic pulmonary hypertension Source: Eur Respir Rev 2015; 24: 272-282 Year: 2015 Incidence of chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism Year: 2011 ERS statement on chronic thromboembolic pulmonary hypertension Source: ERS webinar 2021: ERS statement on chronic thromboembolic pulmonary hypertension Year: 2021 Platelet function in patients with chronic thromboembolic pulmonary hypertension Source: Annual Congress 2009 - Acute and chronic venous thromboembolic disease Year: 2009 Brtain natriuretic peptide in chronic obstructive pulmonary disease under stable state and respiratory failure Source: Eur Respir J 2003; 22: Suppl. 45, 269s Year: 2003 Prevalence of chronic thromboembolic pulmonary hypertension (CTEPH) in patients after pulmonary embolism Source: International Congress 2018 – Clinical aspects of pulmonary hypertension Year: 2018 Platelets and chronic thromboembolic pulmonary hypertension Source: International Congress 2019 – Haemodynamics and chronic thromboembolic pulmonary hypertension Year: 2019 Chronic thromboembolic pulmonary hypertension Source: Eur Respir Mon 2012; 57: 108-118 Year: 2012